Depletion of Aurora A leads to upregulation of FoxO1 to induce cell cycle arrest in hepatocellular carcinoma cells

References

• Carmena M, Earnshaw WC. The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 2003; 4:842 - 54; http://dx.doi.org/10.1038/nrm1245; PMID: 14625535
   PubMed Web of Science ®Google Scholar
• Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998; 17:3052 - 65; http://dx.doi.org/10.1093/emboj/17.11.3052; PMID: 9606188
   PubMed Web of Science ®Google Scholar
• Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 2004; 10:2065 - 71; http://dx.doi.org/10.1158/1078-0432.CCR-1057-03; PMID: 15041727
   PubMed Web of Science ®Google Scholar
• Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998; 20:189 - 93; http://dx.doi.org/10.1038/2496; PMID: 9771714
   PubMed Web of Science ®Google Scholar
• Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, et al. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer 2001; 84:824 - 31; http://dx.doi.org/10.1054/bjoc.2000.1684; PMID: 11259099
   PubMed Web of Science ®Google Scholar
• Kumano M, Miyake H, Terakawa T, Furukawa J, Fujisawa M. Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model. BJU Int 2010; 106:121 - 7; http://dx.doi.org/10.1111/j.1464-410X.2009.09047.x; PMID: 19912186
   PubMed Web of Science ®Google Scholar
• Warner SL, Bearss DJ, Han H, Von Hoff DD. Targeting Aurora-2 kinase in cancer. Mol Cancer Ther 2003; 2:589 - 95; PMID: 12813139
   PubMed Web of Science ®Google Scholar
• Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN Jr., Gandara DR. Aurora kinases as anticancer drug targets. Clin Cancer Res 2008; 14:1639 - 48; http://dx.doi.org/10.1158/1078-0432.CCR-07-2179; PMID: 18347165
   PubMed Web of Science ®Google Scholar
• Wang XX, Liu R, Jin SQ, Fan FY, Zhan QM. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Cell Res 2006; 16:356 - 66; http://dx.doi.org/10.1038/sj.cr.7310046; PMID: 16617331
   PubMed Web of Science ®Google Scholar
• Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 2003; 9:991 - 7; PMID: 12631597
   PubMed Web of Science ®Google Scholar
• Coon TA, Glasser JR, Mallampalli RK, Chen BB. Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest. Cell Cycle 2012; 11:721 - 9; http://dx.doi.org/10.4161/cc.11.4.19171; PMID: 22306998
   PubMed Web of Science ®Google Scholar
• Dar AA, Belkhiri A, El-Rifai W. The aurora kinase A regulates GSK-3beta in gastric cancer cells. Oncogene 2009; 28:866 - 75; http://dx.doi.org/10.1038/onc.2008.434; PMID: 19060929
   PubMed Web of Science ®Google Scholar
• Taga M, Hirooka E, Ouchi T. Essential roles of mTOR/Akt pathway in Aurora-A cell transformation. Int J Biol Sci 2009; 5:444 - 50; http://dx.doi.org/10.7150/ijbs.5.444; PMID: 19564927
   PubMed Web of Science ®Google Scholar
• Briassouli P, Chan F, Savage K, Reis-Filho JS, Linardopoulos S. Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of IkappaBalpha. Cancer Res 2007; 67:1689 - 95; http://dx.doi.org/10.1158/0008-5472.CAN-06-2272; PMID: 17308110
   PubMed Web of Science ®Google Scholar
• Yang G, Chang B, Yang F, Guo X, Cai KQ, Xiao XS, et al. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res 2010; 16:3171 - 81; http://dx.doi.org/10.1158/1078-0432.CCR-09-3171; PMID: 20423983
   PubMed Web of Science ®Google Scholar
• Chefetz I, Holmberg JC, Alvero AB, Visintin I, Mor G. Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway. Cell Cycle 2011; 10:2206 - 14; http://dx.doi.org/10.4161/cc.10.13.16348; PMID: 21623171
   PubMed Web of Science ®Google Scholar
• Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F, et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 2004; 36:55 - 62; http://dx.doi.org/10.1038/ng1279; PMID: 14702041
   PubMed Web of Science ®Google Scholar
• Kaestner P, Stolz A, Bastians H. Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells. Mol Cancer Ther 2009; 8:2046 - 56; http://dx.doi.org/10.1158/1535-7163.MCT-09-0323; PMID: 19584233
   PubMed Web of Science ®Google Scholar
• Gizatullin F, Yao Y, Kung V, Harding MW, Loda M, Shapiro GI. The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Res 2006; 66:7668 - 77; http://dx.doi.org/10.1158/0008-5472.CAN-05-3353; PMID: 16885368
   PubMed Web of Science ®Google Scholar
• Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T, et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 2004; 10:262 - 7; http://dx.doi.org/10.1038/nm1003; PMID: 14981513
   PubMed Web of Science ®Google Scholar
• Hata T, Furukawa T, Sunamura M, Egawa S, Motoi F, Ohmura N, et al. RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 2005; 65:2899 - 905; http://dx.doi.org/10.1158/0008-5472.CAN-04-3981; PMID: 15805292
   PubMed Web of Science ®Google Scholar
• Du J, Hannon GJ. Suppression of p160ROCK bypasses cell cycle arrest after Aurora-A/STK15 depletion. Proc Natl Acad Sci USA 2004; 101:8975 - 80; http://dx.doi.org/10.1073/pnas.0308484101; PMID: 15178765
   PubMed Web of Science ®Google Scholar
• Manfredi MG, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W, et al. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc Natl Acad Sci USA 2007; 104:4106 - 11; http://dx.doi.org/10.1073/pnas.0608798104; PMID: 17360485
   PubMed Web of Science ®Google Scholar
• Huck JJ, Zhang M, McDonald A, Bowman D, Hoar KM, Stringer B, et al. MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo. Mol Cancer Res 2010; 8:373 - 84; http://dx.doi.org/10.1158/1541-7786.MCR-09-0300; PMID: 20197380
   PubMed Web of Science ®Google Scholar
• Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci 2007; 120:2479 - 87; http://dx.doi.org/10.1242/jcs.001222; PMID: 17646672
   PubMed Web of Science ®Google Scholar
• Kelly KR, Nawrocki ST, Espitia CM, Zhang M, Yang JJ, Padmanabhan S, et al. Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism. Int J Cancer 2012; 131:2693 - 703; http://dx.doi.org/10.1002/ijc.27579; PMID: 22488249
   PubMed Web of Science ®Google Scholar
• Kops GJ, Medema RH, Glassford J, Essers MA, Dijkers PF, Coffer PJ, et al. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 2002; 22:2025 - 36; http://dx.doi.org/10.1128/MCB.22.7.2025-2036.2002; PMID: 11884591
   PubMed Web of Science ®Google Scholar
• Medema RH, Kops GJ, Bos JL, Burgering BM. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000; 404:782 - 7; http://dx.doi.org/10.1038/35008115; PMID: 10783894
   PubMed Web of Science ®Google Scholar
• Alvarez B, Martínez-A C, Burgering BM, Carrera AC. Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature 2001; 413:744 - 7; http://dx.doi.org/10.1038/35099574; PMID: 11607034
   PubMed Web of Science ®Google Scholar
• Furukawa-Hibi Y, Yoshida-Araki K, Ohta T, Ikeda K, Motoyama N. FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J Biol Chem 2002; 277:26729 - 32; http://dx.doi.org/10.1074/jbc.C200256200; PMID: 12048180
   PubMed Web of Science ®Google Scholar
• Laoukili J, Kooistra MR, Brás A, Kauw J, Kerkhoven RM, Morrison A, et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 2005; 7:126 - 36; http://dx.doi.org/10.1038/ncb1217; PMID: 15654331
   PubMed Web of Science ®Google Scholar
• Liu Q, Kaneko S, Yang L, Feldman RI, Nicosia SV, Chen J, et al. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J Biol Chem 2004; 279:52175 - 82; http://dx.doi.org/10.1074/jbc.M406802200; PMID: 15469940
   PubMed Web of Science ®Google Scholar
• Mao JH, Wu D, Perez-Losada J, Jiang T, Li Q, Neve RM, et al. Crosstalk between Aurora-A and p53: frequent deletion or downregulation of Aurora-A in tumors from p53 null mice. Cancer Cell 2007; 11:161 - 73; http://dx.doi.org/10.1016/j.ccr.2006.11.025; PMID: 17292827
   PubMed Web of Science ®Google Scholar
• Nair JS, Ho AL, Schwartz GK. The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent. Cell Cycle 2012; 11:807 - 17; http://dx.doi.org/10.4161/cc.11.4.19323; PMID: 22293494
   PubMed Web of Science ®Google Scholar
• Campisi J, d’Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729 - 40; http://dx.doi.org/10.1038/nrm2233; PMID: 17667954
   PubMed Web of Science ®Google Scholar
• Dar AA, Goff LW, Majid S, Berlin J, El-Rifai W. Aurora kinase inhibitors--rising stars in cancer therapeutics?. Mol Cancer Ther 2010; 9:268 - 78; http://dx.doi.org/10.1158/1535-7163.MCT-09-0765; PMID: 20124450
   PubMed Web of Science ®Google Scholar
• Hoellein A, Pickhard A, von Keitz F, Schoeffmann S, Piontek G, Rudelius M, et al. Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck. Oncotarget 2011; 2:599 - 609; PMID: 21865609
   PubMed Web of Science ®Google Scholar
• Nakae J, Park BC, Accili D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J Biol Chem 1999; 274:15982 - 5; http://dx.doi.org/10.1074/jbc.274.23.15982; PMID: 10347145
   PubMed Web of Science ®Google Scholar
• Zhu G, Spellman PT, Volpe T, Brown PO, Botstein D, Davis TN, et al. Two yeast forkhead genes regulate the cell cycle and pseudohyphal growth. Nature 2000; 406:90 - 4; http://dx.doi.org/10.1038/35021046; PMID: 10894548
   PubMed Web of Science ®Google Scholar
• Hwang A, Maity A, McKenna WG, Muschel RJ. Cell cycle-dependent regulation of the cyclin B1 promoter. J Biol Chem 1995; 270:28419 - 24; http://dx.doi.org/10.1074/jbc.270.47.28419; PMID: 7499347
   PubMed Web of Science ®Google Scholar
• Pines J. Mitosis: a matter of getting rid of the right protein at the right time. Trends Cell Biol 2006; 16:55 - 63; http://dx.doi.org/10.1016/j.tcb.2005.11.006; PMID: 16337124
   PubMed Web of Science ®Google Scholar
• Lindon C, Pines J. Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells. J Cell Biol 2004; 164:233 - 41; http://dx.doi.org/10.1083/jcb.200309035; PMID: 14734534
   PubMed Web of Science ®Google Scholar
• Jackson JR, Patrick DR, Dar MM, Huang PS. Targeted anti-mitotic therapies: can we improve on tubulin agents?. Nat Rev Cancer 2007; 7:107 - 17; http://dx.doi.org/10.1038/nrc2049; PMID: 17251917
   PubMed Web of Science ®Google Scholar
• Hirota T, Kunitoku N, Sasayama T, Marumoto T, Zhang D, Nitta M, et al. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 2003; 114:585 - 98; http://dx.doi.org/10.1016/S0092-8674(03)00642-1; PMID: 13678582
   PubMed Web of Science ®Google Scholar
• Marumoto T, Honda S, Hara T, Nitta M, Hirota T, Kohmura E, et al. Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. J Biol Chem 2003; 278:51786 - 95; http://dx.doi.org/10.1074/jbc.M306275200; PMID: 14523000
   PubMed Web of Science ®Google Scholar
• van der Horst A, Burgering BM. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 2007; 8:440 - 50; http://dx.doi.org/10.1038/nrm2190; PMID: 17522590
   PubMed Web of Science ®Google Scholar